Gavin Thurston

Molecular Biology · 2000–2010

A researcher in the Science corpus: 14 papers; trusts 1 researcher and is trusted by 10 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 80 citations into it; #4,332 of 17,773 by trust here, #1,741 by citations
• Cancer Research — 28 citations into it; #758 of 1,780 by trust here, #462 by citations

Whom Gavin Thurston trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Rakesh K. Jain

Who trusts Gavin Thurston overall

1. Peter Carmeliet
2. K. Alitalo
3. Rakesh K. Jain
4. T. Tammela
5. Ulrike Fiedler
6. H. Augustin
7. M. Potente
8. N. Ferrara

Papers from Gavin Thurston's perspective

Ordered by how strongly the researchers Gavin Thurston trusts endorse each paper. Same corpus, a different order for every researcher.

1. Angiopoietin-1 protects the adult vasculature against plasma leakage (Nature Medicine)
2. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
3. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (Cancer Cell)
4. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
5. Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
6. Angiogenesis in health and disease (Nature Medicine)
7. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. (American Journal of Pathology)
8. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
9. Molecular regulation of vessel maturation (Nature Medicine)
10. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. (Blood)

Their papers

• Angiopoietin-1 protects the adult vasculature against plasma leakage (2000) — 1,353 citations
• Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (2004) — 759 citations
• Openings between defective endothelial cells explain tumor vessel leakiness. (2000) — 1,654 citations
• Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system (2009) — 1,423 citations
• Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting (2010) — 964 citations
• VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. (2006) — 786 citations
• Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice (2001) — 691 citations
• Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis (2006) — 1,009 citations
• The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. (2004) — 760 citations
• Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. (2002) — 1,052 citations
• Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. (2004) — 635 citations
• Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation (2006) — 989 citations
• CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. (2008) — 976 citations
• Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting (2007) — 797 citations